Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1443049-84-0 | MDL No. : | MFCD28975107 |
Formula : | C27H18ClN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PGIGQFHBEHJSQN-UHFFFAOYSA-N |
M.W : | 419.91 | Pubchem ID : | 91972125 |
Synonyms : |
|
Num. heavy atoms : | 31 |
Num. arom. heavy atoms : | 30 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 126.58 |
TPSA : | 38.67 Ų |
GI absorption : | Low |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -3.45 cm/s |
Log Po/w (iLOGP) : | 4.75 |
Log Po/w (XLOGP3) : | 7.62 |
Log Po/w (WLOGP) : | 7.19 |
Log Po/w (MLOGP) : | 5.49 |
Log Po/w (SILICOS-IT) : | 7.09 |
Consensus Log Po/w : | 6.43 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 1.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -7.7 |
Solubility : | 0.00000845 mg/ml ; 0.0000000201 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -8.27 |
Solubility : | 0.00000225 mg/ml ; 0.0000000054 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -11.87 |
Solubility : | 0.0000000006 mg/ml ; 0.0 mol/l |
Class : | Insoluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.84 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With tri-tert-butyl phosphine; palladium diacetate; sodium t-butanolate In toluene at 110℃; for 12h; | 1 [Synthesis example 1] Synthesis of compound Inv 5 Core (5.0 g, 13.95 mmol) obtained in Step 3 of [Preparation Example 1] and 2-(3'-chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine (4.61 g, 16.74 mmol)and Pd(OAc)2 (0.094 g, 0.41 mmol), P(t-Bu)3 (0.28 g, 13.95 mmol),sodium tert-butoxide (2.68 g, 27.89 mmol) was added to 80 ml toluene and the mixture was stirred at 110 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO4. After removing the solvent of the filtered organic layer, Inv 5 (6.8 g, yield 65%) was obtained by column chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | With palladium diacetate; caesium carbonate; XPhos In ethanol; water; toluene for 4h; Heating; | 11 [Synthesis Example 11] Synthesis of Compound 48 2.3 g of 2- (3'-chloro-[1,1 '-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine and 2.4g of the compound SAF- 3B and 3.0 g of Cs2CO3 were mixed, 60 ml of toluene, 12 ml of ethanol and 12 ml of water were added, and then 55 mg of Pd(OAc) 2 and 250 mg of Xphos were added and the mixture was heated and stirred for 4 hours. After completion of the reaction, the temperature was lowered to room temperature and then filtered. The filtrate was poured into water and extracted with chloroform. The organic layer was dried over MgSO4, concentrated under reduced pressure, and then subjected to column chromatography with THF: Hex = 1: 3 to obtain Compound 48 (2.6 g, yield: 63%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In tetrahydrofuran; water for 12h; Reflux; | 41 [Synthesis Example 41] Synthesis of Compound A-41 Target compound of Preparation Example 6 (5.0 g, 11.7 mmol), 2-(3'-chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine ( 6.4 g, 15.2 mmol) and Pd(PPh3)4(0.7 g, 0.6 mmol), K2CO3(4.9 g, 35.2 mmol) wereadded to a mixtureof THF 100ml and H2O 30ml and heated to reflux for 12 hours. .After completion of the reaction, the mixture was extracted with methylene chloride, MgSO4was added and filtered.After removing the solvent of the filtered organic layer, A-41 (4.4 g, yield 55%) as a target compound was obtained using column chromatography. |
[ 1443049-86-2 ]
2-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.98
[ 1205748-61-3 ]
2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine
Similarity: 0.75
[ 919301-53-4 ]
4-(4-Chlorophenyl)-2,6-diphenylpyrimidine
Similarity: 0.75
[ 14544-47-9 ]
4,4',4''-(1,3,5-Triazine-2,4,6-triyl)trianiline
Similarity: 0.73
[ 1700-02-3 ]
2,4-Dichloro-6-phenyl-1,3,5-triazine
Similarity: 0.70
[ 1443049-86-2 ]
2-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.98
[ 1205748-61-3 ]
2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine
Similarity: 0.75
[ 919301-53-4 ]
4-(4-Chlorophenyl)-2,6-diphenylpyrimidine
Similarity: 0.75
[ 60518-41-4 ]
7-Chloro-3,4-dihydroisoquinoline
Similarity: 0.71
[ 1443049-86-2 ]
2-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.98
[ 1205748-61-3 ]
2,4-Di([1,1'-biphenyl]-3-yl)-6-chloro-1,3,5-triazine
Similarity: 0.75
[ 14544-47-9 ]
4,4',4''-(1,3,5-Triazine-2,4,6-triyl)trianiline
Similarity: 0.73
[ 1700-02-3 ]
2,4-Dichloro-6-phenyl-1,3,5-triazine
Similarity: 0.70
[ 203450-08-2 ]
2-(4-Fluorophenyl)-4,6-diphenyl-1,3,5-triazine
Similarity: 0.68